chr10-19817156-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_032812.9(PLXDC2):āc.77A>Gā(p.Gln26Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000184 in 1,575,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_032812.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLXDC2 | NM_032812.9 | c.77A>G | p.Gln26Arg | missense_variant | 1/14 | ENST00000377252.5 | NP_116201.7 | |
PLXDC2 | NM_001282736.2 | c.77A>G | p.Gln26Arg | missense_variant | 1/13 | NP_001269665.1 | ||
PLXDC2 | XM_011519750.3 | c.77A>G | p.Gln26Arg | missense_variant | 1/14 | XP_011518052.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLXDC2 | ENST00000377252.5 | c.77A>G | p.Gln26Arg | missense_variant | 1/14 | 1 | NM_032812.9 | ENSP00000366460.3 | ||
PLXDC2 | ENST00000377242.7 | c.77A>G | p.Gln26Arg | missense_variant | 1/13 | 1 | ENSP00000366450.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000155 AC: 3AN: 193928Hom.: 0 AF XY: 0.0000193 AC XY: 2AN XY: 103824
GnomAD4 exome AF: 0.0000176 AC: 25AN: 1423510Hom.: 0 Cov.: 32 AF XY: 0.0000156 AC XY: 11AN XY: 704628
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74328
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at